Puma Biotechnology (0PB) Ratios
Puma Biotechnology Ratios
DE:0PB's free cash flow for Q2 2026 was $1.62M. For the 2026 fiscal year, DE:0PB's free cash flow was increased by $0.00 and operating cash flow was $1.62M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.00 | 1.54 | 1.57 | 1.73 | 1.28 |
| Quick Ratio | 1.93 | 1.45 | 1.50 | 1.67 | 1.21 |
| Cash Ratio | 0.36 | 0.72 | 0.85 | 0.98 | 0.58 |
| Solvency Ratio | 0.49 | 0.34 | 0.19 | 0.05 | -0.08 |
| Operating Cash Flow Ratio | 0.51 | 0.40 | 0.27 | -0.20 | 0.19 |
| Short-Term Operating Cash Flow Coverage | 1.86 | 0.86 | 0.79 | 0.00 | 0.00 |
| Net Current Asset Value | $ 76.72M | $ 26.45M | $ -20.90M | $ -66.17M | $ -89.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.35 | 0.48 | 0.51 | 0.51 |
| Debt-to-Equity Ratio | 0.22 | 0.80 | 2.09 | 5.29 | -47.69 |
| Debt-to-Capital Ratio | 0.18 | 0.45 | 0.68 | 0.84 | 1.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.19 | 0.55 | 0.82 | 1.03 |
| Financial Leverage Ratio | 1.66 | 2.32 | 4.31 | 10.28 | -92.63 |
| Debt Service Coverage Ratio | 1.67 | 0.94 | 0.98 | 1.85 | -0.39 |
| Interest Coverage Ratio | 5.63 | 2.49 | 2.45 | 2.05 | 0.10 |
| Debt to Market Cap | 0.08 | 0.45 | 0.49 | 0.52 | 0.79 |
| Interest Debt Per Share | 0.70 | 1.78 | 2.65 | 2.82 | 3.19 |
| Net Debt to EBITDA | -0.02 | 0.10 | 0.57 | 1.74 | -11.41 |
| Profitability Margins | |||||
| Gross Profit Margin | 74.53% | 72.06% | 73.40% | 75.84% | 74.84% |
| EBIT Margin | 18.57% | 15.86% | 15.28% | 5.28% | -6.32% |
| EBITDA Margin | 23.36% | 20.86% | 20.17% | 9.60% | -1.85% |
| Operating Profit Margin | 16.33% | 13.44% | 13.85% | 10.40% | 0.51% |
| Pretax Profit Margin | 15.67% | 10.46% | 9.62% | 0.20% | -11.38% |
| Net Profit Margin | 13.62% | 13.14% | 9.16% | 0.00% | -11.51% |
| Continuous Operations Profit Margin | 13.62% | 13.14% | 9.16% | 0.00% | -11.51% |
| Net Income Per EBT | 86.95% | 125.63% | 95.22% | 0.44% | 101.12% |
| EBT Per EBIT | 95.93% | 77.83% | 69.47% | 1.93% | -2232.71% |
| Return on Assets (ROA) | 14.38% | 14.19% | 9.37% | 0.00% | -12.85% |
| Return on Equity (ROE) | 23.87% | 32.87% | 40.40% | 0.01% | 1190.76% |
| Return on Capital Employed (ROCE) | 27.62% | 26.42% | 24.89% | 16.41% | 1.10% |
| Return on Invested Capital (ROIC) | 20.41% | 18.42% | 18.29% | 0.07% | 1.07% |
| Return on Tangible Assets | 17.79% | 18.67% | 12.73% | 0.00% | -18.15% |
| Earnings Yield | 10.46% | 20.41% | 10.58% | 0.00% | -23.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.26 | 7.20 | 4.86 | 5.39 | 7.78 |
| Payables Turnover | 11.50 | 11.69 | 9.10 | 8.55 | 5.70 |
| Inventory Turnover | 10.55 | 7.38 | 8.85 | 12.17 | 8.96 |
| Fixed Asset Turnover | 41.07 | 45.24 | 27.25 | 18.23 | 16.05 |
| Asset Turnover | 1.06 | 1.08 | 1.02 | 1.03 | 1.12 |
| Working Capital Turnover Ratio | 3.43 | 4.25 | 4.15 | 5.23 | 8.12 |
| Cash Conversion Cycle | 88.63 | 68.92 | 76.22 | 54.98 | 23.60 |
| Days of Sales Outstanding | 85.75 | 50.70 | 75.11 | 67.66 | 46.90 |
| Days of Inventory Outstanding | 34.61 | 49.44 | 41.23 | 29.99 | 40.73 |
| Days of Payables Outstanding | 31.73 | 31.22 | 40.11 | 42.67 | 64.03 |
| Operating Cycle | 120.37 | 100.14 | 116.34 | 97.65 | 87.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.84 | 0.80 | 0.57 | -0.35 | 0.51 |
| Free Cash Flow Per Share | 0.83 | 0.80 | 0.30 | -0.51 | 0.51 |
| Dividend Paid and CapEx Coverage Ratio | 588.76 | 694.96 | 2.14 | -2.26 | 0.00 |
| Capital Expenditure Coverage Ratio | 588.76 | 694.96 | 2.14 | -2.26 | 0.00 |
| Operating Cash Flow Coverage Ratio | 1.46 | 0.53 | 0.24 | -0.14 | 0.18 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.17 | 0.11 | -0.07 | 0.08 |
| Free Cash Flow Yield | 14.02% | 26.19% | 7.04% | -12.08% | 16.71% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.60 | 4.92 | 9.45 | 94486.57 | -4.24 |
| Price-to-Sales (P/S) Ratio | 1.30 | 0.64 | 0.87 | 0.83 | 0.49 |
| Price-to-Book (P/B) Ratio | 2.28 | 1.61 | 3.82 | 8.75 | -50.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.13 | 3.82 | 14.20 | -8.28 | 5.98 |
| Price-to-Operating Cash Flow Ratio | 7.12 | 3.81 | 7.56 | -11.94 | 5.98 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.14 | 0.00 | -918.83 | 0.08 |
| Enterprise Value Multiple | 5.56 | 3.19 | 4.86 | 10.37 | -37.75 |
| Enterprise Value | 296.48M | 153.24M | 231.00M | 227.05M | 177.05M |
| EV to EBITDA | 5.56 | 3.19 | 4.86 | 10.37 | -37.75 |
| EV to Sales | 1.30 | 0.66 | 0.98 | 1.00 | 0.70 |
| EV to Free Cash Flow | 7.10 | 3.94 | 16.08 | -9.95 | 8.57 |
| EV to Operating Cash Flow | 7.09 | 3.94 | 8.55 | -14.35 | 8.57 |
| Tangible Book Value Per Share | 1.78 | 0.84 | -0.16 | -1.10 | -1.69 |
| Shareholders’ Equity Per Share | 2.61 | 1.89 | 1.13 | 0.48 | -0.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | -0.26 | 0.05 | 1.00 | -0.01 |
| Revenue Per Share | 4.57 | 4.74 | 5.00 | 5.10 | 6.23 |
| Net Income Per Share | 0.62 | 0.62 | 0.46 | 0.00 | -0.72 |
| Tax Burden | 0.87 | 1.26 | 0.95 | 0.00 | 1.01 |
| Interest Burden | 0.84 | 0.66 | 0.63 | 0.04 | 1.80 |
| Research & Development to Revenue | 0.27 | 0.24 | 0.21 | 0.23 | 0.28 |
| SG&A to Revenue | 0.31 | 0.35 | 0.38 | 0.39 | 0.46 |
| Stock-Based Compensation to Revenue | 0.03 | 0.04 | 0.04 | 0.05 | 0.13 |
| Income Quality | 1.34 | 1.29 | 1.25 | -7913.50 | -0.71 |
Currency in USD
